[go: up one dir, main page]

BRPI0812222A2 - Compostos ciclobutenodiona substituídos anti-inflamatórios. - Google Patents

Compostos ciclobutenodiona substituídos anti-inflamatórios.

Info

Publication number
BRPI0812222A2
BRPI0812222A2 BRPI0812222-9A2A BRPI0812222A BRPI0812222A2 BR PI0812222 A2 BRPI0812222 A2 BR PI0812222A2 BR PI0812222 A BRPI0812222 A BR PI0812222A BR PI0812222 A2 BRPI0812222 A2 BR PI0812222A2
Authority
BR
Brazil
Prior art keywords
cyclobutention
inflammatory
compounds replaced
replaced anti
compounds
Prior art date
Application number
BRPI0812222-9A2A
Other languages
English (en)
Inventor
Neil John Press
Simon James Watson
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0812222A2 publication Critical patent/BRPI0812222A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0812222-9A2A 2007-06-06 2008-06-04 Compostos ciclobutenodiona substituídos anti-inflamatórios. BRPI0812222A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07109704 2007-06-06
PCT/EP2008/056902 WO2008148790A1 (en) 2007-06-06 2008-06-04 Anti -inflammatory substituted cyclobutenedione compounds

Publications (1)

Publication Number Publication Date
BRPI0812222A2 true BRPI0812222A2 (pt) 2014-12-16

Family

ID=38626949

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812222-9A2A BRPI0812222A2 (pt) 2007-06-06 2008-06-04 Compostos ciclobutenodiona substituídos anti-inflamatórios.

Country Status (13)

Country Link
US (1) US8183281B2 (pt)
EP (1) EP2155670B1 (pt)
JP (1) JP2010529079A (pt)
KR (1) KR20100031718A (pt)
CN (1) CN101772485A (pt)
AT (1) ATE554066T1 (pt)
AU (1) AU2008258588B2 (pt)
BR (1) BRPI0812222A2 (pt)
CA (1) CA2689581A1 (pt)
EA (1) EA200901612A1 (pt)
ES (1) ES2386489T3 (pt)
MX (1) MX2009013276A (pt)
WO (1) WO2008148790A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA103198C2 (en) 2008-08-04 2013-09-25 Новартис Аг Squaramide derivatives as cxcr2 antagonists
US8648118B2 (en) 2010-12-17 2014-02-11 Boehringer Ingelheim International Gmbh Bicyclic ring system substituted amide functionalised phenols as medicaments
US8648070B2 (en) * 2010-12-17 2014-02-11 Boehringer Ingelheim International Gmbh Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
EP2760821B1 (en) 2011-09-02 2017-10-11 Novartis AG Choline salt of an anti-inflammatory substituted cyclobutenedione compound
FR2981934B1 (fr) * 2011-10-28 2013-12-20 Galderma Res & Dev Nouveaux composes di-substitues de la diamino-3,4-cyclobutene-3-dione-1,2 utiles dans le traitement de pathologies mediees par des chimiokines.
FR2981935B1 (fr) * 2011-10-28 2015-08-07 Galderma Res & Dev Nouveaux composes di-substitues de la diamino-3,4-cyclobutene-3-dione-1,2 utiles dans le traitement de pathologies mediees par des chimiokines.
CZ2014321A3 (cs) * 2014-05-09 2016-01-13 Vysoká škola chemicko- technologická v Praze Dioxocyklobutenylhydrazony a jejich protirakovinné účinky
FR3030515B1 (fr) * 2014-12-23 2017-01-20 Galderma Res & Dev Nouveaux composes antagonistes des recepteurs cxcr1 et cxcr2 aux chimiokines, et leur utilisation dans le traitement de pathologies mediees par des chimiokines
TWI734715B (zh) 2015-11-19 2021-08-01 美商卡默森屈有限公司 趨化因子受體調節劑
TWI724056B (zh) 2015-11-19 2021-04-11 美商卡默森屈有限公司 Cxcr2抑制劑
AU2018318075B2 (en) * 2017-08-14 2023-04-13 Allergan, Inc. 3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof
US11207294B2 (en) 2018-01-08 2021-12-28 Chemocentryx, Inc. Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2
MX2021003318A (es) 2018-09-21 2021-05-14 Pfizer Dioxociclobutenilamino-3-hidroxi-picolinamidas n-sustituidas utiles como inhibidores de ccr6.
CN109824629B (zh) * 2019-02-27 2022-12-09 南京工业大学 一种利用N-乙酰氨基葡萄糖制备3-氨基-5-(α-氨基乙基)四氢呋喃的方法
MX2022002374A (es) 2019-08-28 2022-03-29 Novartis Ag Derivados de 1,3-fenil heteroarilo sustituidos y su uso en el tratamiento de enfermedades.
CN112759549B (zh) * 2019-11-05 2023-07-28 中国医学科学院药物研究所 3-取代氨基-4-((取代吡啶基)氨基)环丁-3-烯-1,2-二酮类化合物
CN112851635B (zh) * 2019-11-28 2022-09-16 中国医学科学院药物研究所 环状砜类化合物及其制备方法、用途和药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166050A (en) * 1998-12-14 2000-12-26 American Home Products Corporation 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by VLA-4
EP1351933B1 (en) 2001-01-16 2006-11-22 SmithKline Beecham Corporation Il-8 receptor antagonists
US20040106794A1 (en) 2001-04-16 2004-06-03 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
KR20100008794A (ko) * 2001-04-16 2010-01-26 쉐링 코포레이션 Cxc-케모카인 수용체 리간드로서의 3,4-이치환된 사이클로부텐-1,2-디온
US7132445B2 (en) 2001-04-16 2006-11-07 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
CN100444839C (zh) 2002-03-18 2008-12-24 先灵公司 式(i)化合物在制备治疗化学激活物中介的疾病的药物中的应用

Also Published As

Publication number Publication date
AU2008258588A1 (en) 2008-12-11
ATE554066T1 (de) 2012-05-15
MX2009013276A (es) 2010-01-25
US20100125071A1 (en) 2010-05-20
AU2008258588B2 (en) 2011-11-10
KR20100031718A (ko) 2010-03-24
WO2008148790A1 (en) 2008-12-11
WO2008148790A8 (en) 2010-01-07
EA200901612A1 (ru) 2010-06-30
AU2008258588A8 (en) 2010-05-13
CA2689581A1 (en) 2008-12-11
JP2010529079A (ja) 2010-08-26
US8183281B2 (en) 2012-05-22
EP2155670B1 (en) 2012-04-18
ES2386489T3 (es) 2012-08-21
EP2155670A1 (en) 2010-02-24
CN101772485A (zh) 2010-07-07

Similar Documents

Publication Publication Date Title
BRPI0812222A2 (pt) Compostos ciclobutenodiona substituídos anti-inflamatórios.
CY1119515T1 (el) Οξαζολο υποκατεστημενα ινδαζολια ως αναστολεις ρι3-κινασης
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
UA107791C2 (en) Pesticidal compositions
ECSP10010722A (es) Compuestos orgánicos
CR11021A (es) Derivados de quinolina como fungicidas
EA201000395A1 (ru) Фунгицидные производные 2-алкилтио-2-хинолинилоксиацетамида
ATE483000T1 (de) Naphtalin-amidin-imide
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
EA201070519A1 (ru) Соединения тропана
MA32811B1 (fr) Nouveaux composés
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
DE602006009789D1 (de) Acetylenderivate
EA201101060A1 (ru) Новые гербициды
EA201101099A1 (ru) Гербициды, полученные из циклопентадиона
EA201101148A1 (ru) Новые гербициды
CR10955A (es) Nuevo procedimiento de sintesis de la agomelatina
UA106880C2 (uk) Нові гербіциди
EA201101146A1 (ru) Новые гербициды
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
CR10960A (es) Nuevo procedimiento de sintesis de la agomelatina
UY31688A1 (es) Plaguicidas
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.